Levothyroxine Sodium
Drug
Mylan Inc.
Total Payments
$221,000
Transactions
5
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $44,200 | 2 | 0 |
| 2019 | $176,800 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $221,000 | 5 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 11932904 | Mylan Inc. | $176,800 | 0 |
| LVOS-1-19094 | DPT Laboratories, Ltd. | $44,200 | 0 |
Top Doctors Receiving Payments for Levothyroxine Sodium
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $221,000 | 5 |
Ad
Manufacturing Companies
- Mylan Inc. $176,800
- DPT Laboratories, Ltd. $44,200
Product Information
- Type Drug
- Total Payments $221,000
- Total Doctors 0
- Transactions 5
About Levothyroxine Sodium
Levothyroxine Sodium is a drug associated with $221,000 in payments to 0 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Mylan Inc..
Payment data is available from 2019 to 2020. In 2020, $44,200 was paid across 2 transactions to 0 doctors.
The most common payment nature for Levothyroxine Sodium is "Unspecified" ($221,000, 100.0% of total).
Levothyroxine Sodium is associated with 2 research studies, including "11932904" ($176,800).